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Abstract 
Genetically engineered protein polymers functionalized with bioactive domains offer 
potential as multifunctional versatile materials for biomedical use. The present work 
describes the fabrication and characterization of antimicrobial fibre mats comprising the 
antimicrobial elastin-like recombinamer CM4-A200. The CM4-A200 protein polymer 
derives from the genetic fusion of the ABP-CM4 antimicrobial peptide from Bombyx mori 
with 200 repetitions of the pentamer VPAVG. This is the first report on non-crosslinked 
fibre mats fabricated with an antimicrobial elastin-like recombinamer stable in solution. 
Thermal gravimetric analysis of CM4-A200 fibre mats shows one single degradation step 
at temperatures above 300 ºC, with fibres displaying a higher thermal degradation 
activation. The electrospun CM4-A200 fibres display high antimicrobial activity against 
Gram-positive and Gram-negative bacteria with no detectable cytotoxic effects against 
normal human skin fibroblasts and keratinocytes, revealing the great potential of these 
polymers for the fabrication of biomedical materials. 
 
Keywords: Recombinamers, elastin-like polypeptide, antimicrobial activity, 
electrospinning, antimicrobial peptide. 
 
Running head: Antimicrobial fibre mats of a bioengineered protein-based polymer 
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Introduction 
Within the materials used for biomaterials manufacturing, natural polymers attract great 
attention due to the superior biocompatibility and low immunogenicity when compared 
with synthetic polymeric materials. Recombinant protein-based polymers (rPBPs) are 
biopolymers comprising tandem repetitions of amino acid sequences, by using the 
knowledge obtained from the observation of natural proteins [1]. These protein 
polymers are produced by recombinant DNA technology, allowing to precisely control 
their molecular structure. This potential can be explored to create customized materials 
by incorporating functionalities that otherwise would not be present [2-5]. Elastin-like 
recombinamers (ELRs) are elastin-mimetic rPBPs with amino acid sequence deriving 
from the hydrophobic domain of tropoelastin. Typically, ELRs consist of repeats of the 
pentamer (VPGXG), where X, the guest residue, is any amino acid except proline [6]. 
The most remarkable features of ELRs include the ability to undergo reversible, 
temperature-dependent, hydrophobic assembly from aqueous solution [6] and 
extraordinary good biocompatibility [7-9]. However, the high solubility of ELR 
materials in aqueous solutions at temperatures below their transition temperature, 
hampers their usage in the development of new biomaterials. In general, the structural 
integrity of ELR materials can be maintained by including lysine residues in the guest 
residue to provide free amine groups to react with the crosslinking agent [10-12]. For 
instance, electrospun fibre mats of an ELR with sequence VPGKG were structurally 
stabilized via a two-step method involving a vapor-phase and further aqueous 
completion of crosslinks by using glutaraldehyde [11]. Similarly, electrospun fibre mats 
of ELRs containing cell adhesion domains were stabilized via crosslinking through the 
lysine residues of the VPGKG sequence, using genipin [13] or HDMI/acetone solution 
[14]. Still, the uncontrolled chemical crosslinking via lysine residues can lead to a loss 
of properties in ELR-based polypeptides with bioactive domains enriched in such 
residues. In addition, the extensive crosslinking within the VPGXG may preclude its 
proper folding leading to a loss of properties. Other fibre stabilization procedures 
involve blending the ELR with other polymers such as polycaprolactone [15] and 
methacrylate [16]. Nevertheless, these approaches may exert a negative impact in the 
bioactivity and mechanical properties of the ELR fibres. An alternative to the 
crosslinking step is to explore the thermal hysteresis of poly(VPAVG). The pentamer 
VPAVG is unique among ELRs, self-assembling at temperatures above 33 ºC but only 
disassembles when the temperature is strongly cooled down to ~12 ºC [3, 17-19]. This 
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preserves the structural integrity of ELR-based materials within a broad range of 
temperatures.  
As the development of antimicrobial materials is a rapidly growing field, particularly 
for the biomedical field, there is a demand for new versatile materials [20]. This is 
particularly relevant due to the advent of multidrug resistance in bacterial pathogens. 
The overuse and misuse of antibiotics over decades have exerted an unprecedented 
selective pressure on bacteria resulting in multi-antibiotic resistant organisms [21, 22]. 
This represents a major danger to public health as it threatens our ability to treat 
common infectious diseases with conventional antimicrobials, resulting in prolonged 
illness and an economic burden in healthcare settings [23, 24].Consequently, great 
efforts are put into the research of new and effective antimicrobials as well as in 
infection prevention strategies that do not require antibiotics [25]. Antimicrobial 
peptides (AMPs) are considered a promising alternative to tackle multidrug resistant 
bacteria [26-28]. This class of small immunomodulatory peptides is found in almost all 
living organisms, representing the first line of defence of multicellular organisms as part 
of their innate immune system [26, 29]. Typically, AMPs are characterized by small 
molecular weight, cationic net charge, amphipathic structure and broad antimicrobial 
activity against bacteria, fungi and viruses [28]. Another remarkable feature of AMPs is 
that they act against bacteria but are essentially harmless to mammalian cells [29, 30]. 
This selectivity towards bacterial cells and the nature of the antimicrobial mechanism 
highlight the potential of AMPs for innovative antimicrobial therapies.  
Our team developed the genetically engineered polymer CM4-A200 [4] which 
combines in the same macromolecule the antimicrobial peptide ABP-CM4, isolated 
from the Chinese silkworm [31], and the ELR (VPAVG)200 [17]. In this work we report 
the fabrication of stable antimicrobial CM4-A200 fibre mats without the need of 
crosslinking agents, demonstrating its potential use for skin tissue engineering and 
wound healing applications. 
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Methods 
Materials:  
The recombinant CM4-A200 protein was obtained by heterologous production using 
Escherichia coli as cell factory [4]. Pure lyophilized CM4-A200 was completely 
dissolved in formic acid (FA, ≥ 98 %, MERCK) for a final concentration of 20 % (w/v). 
The solutions were maintained at ice-cold temperature, dissolved with the help of a 
magnetic stirrer until complete dissolution, and allowed to set at room temperature (RT) 
for 30 min before processing.  
 
Sample preparation: 
Fibres. A custom-build electrospinning apparatus was used for the fabrication of 
fibrous membranes. The 20 % (w/v) polymer solution was transferred to a plastic 
syringe fitted with a steel needle with an inner diameter of 0.5 mm. Electrospinning was 
conducted with an electric field ranging from 1.35 kV.cm-1, applied with a high voltage 
power supply from Gamma High Voltage. A syringe pump (KDScientific) was used to 
feed the polymer solutions into the needle tip at a feed rate of 0.1 mL.h-1 and the 
electrospun fibre mats were collected in a static grounded aluminium plate, placed at 15 
cm from the needle tip. The as-spun fibres were stored for at least 72 h before any 
characterization to allow complete solvent evaporation.  
Films. In some cases, free standing films were produced by solvent casting 
using 10 % (w/v) CM4-A200 formic acid solution and cast on polytetrafluoroethylene 
substrates with 10 mm diameter [4]. The solvent was evaporated at RT for 48 h under 
extraction.   
 
Morphological analysis: 
The morphology of the fibre membranes was observed under a scanning electron 
microscope (SEM, FEI Nova 200) with an accelerating voltage of 3 kV. The average 
fibre diameter was calculated with at least 100 randomly selected fibres from different 
micrographs, using ImageJ image processing software [32]. 
 
Fourier transform infrared spectroscopy with attenuated total reflectance (ATR-FTIR):  
FTIR spectra from 4000 cm-1 to 600 cm-1 were acquired at room temperature with a 
Bruker Tensor 27 in ATR mode. The spectra were collected with a resolution of 2 cm-1 
after 64 scans. 
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 Thermal analysis: 
Thermal changes were assessed by differential scanning calorimetry measurements 
(DSC) and thermogravimetric analysis (TGA). DSC experiments were carried with a 
Mettler Toledo DSC 823e with liquid nitrogen as cooler. The samples were cut into 
small pieces from the middle region, and placed into 50 µl aluminium pans followed by 
a heating step from 35 ºC to 200 ºC with a constant heating rate of 10 ºC.min-1. The 
thermal degradation kinetics were assessed in a Perkin-Elmer Pyris 1 TGA apparatus 
with different heating rate scans (from 10 ºC to 40 ºC.min-1), under a nitrogen 
atmosphere. Analysis of the collected data was performed using the OriginPro software 
(OriginLab, Northampton, MA). All samples were air-dried for at least 48 h prior to any 
characterization study. 
 
Degree of swelling and hydrolytic degradation:  
The degree of swelling for the CM4-A200 fibres was assessed by measuring the 
difference in weight between dry and swollen samples. Fibre mats were immersed in 
PBS 1x (NaCl 8 g, KCl 0.2 g, Na2HPO4 1.44 g, KH2PO4 0.24 g, per litre, at pH 7.4) at 
RT and collected at regular intervals. At each time point, the samples were taken after 
immersion and the excess of liquid was gently removed with filter paper. The degree of 
swelling was then calculated using Equation 1:  
 
𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 𝑠𝑤𝑒𝑙𝑙𝑖𝑛𝑔 (%) = (
𝑊𝑠−𝑊𝑑
𝑊𝑑
)×100   (1) 
 
where Ws is the mass of the swollen sample and Wd is the initial dry mass. Each value 
was averaged from three independent measurements. 
The hydrolytic degradation of the fibres was evaluated in PBS 1x solution. The samples 
were immersed in PBS 1x (15 mL) and incubated at 37 ºC for different time periods, 
with PBS renewal every 72 h. After the incubation time, the samples were washed with 
ultrapure water to remove PBS and air-dried at RT until reaching a constant mass. The 
extent of hydrolytic degradation was calculated by weighing the samples before and 
after incubation in an analytical microbalance (Mettler Toledo, error ± 0.1 mg) 
according to Equation 2. All measurements were performed in triplicate. 
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%𝑀𝐿 = (1 −
𝑀𝑓
𝑀𝑖
) ×100     (2) 
 
where ML is mass loss in percentage, Mf is the sample mass after the incubation time 
and Mi is the initial sample mass. 
 
Evaluation of antibacterial activity: 
The antimicrobial activity of the electrospun fibres was assessed using a modified 
protocol based on a previously described assay [4]. Prior to cell incubation, the fibres 
were cut into 100 mm2 samples and sterilized by UV exposure for 30 min at a 
wavelength of 254 nm. The fibres were then transferred to sterile 24 well plates and a 
stainless steel nut was placed on top of the samples to delimitate the area of inoculation 
and to avoid material bending. Fibre samples were inoculated with 15 µl of bacterial 
cell suspension at a concentration of 1x107 CFUs/mL, followed by incubation at 37 ºC 
for 30 and 120 min. After incubation, 1 mL of sterile PBS was added and carefully 
agitated prior plating on LB agar for bacterial CFUs enumeration. Pseudomonas 
aeruginosa ATCC10145 and Staphylococcus aureus ATCC6538 were used as a model 
Gram-negative and a Gram-positive bacteria, respectively and 100 mm2 aluminium foil 
squares were used as negative control. All measurements were performed in triplicate 
and results expressed as % kill using Equation 3:  
% 𝑘𝑖𝑙𝑙 =
(𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝐶𝐹𝑈𝑠−𝑆𝑎𝑚𝑝𝑙𝑒 𝐶𝐹𝑈𝑠)
𝐶𝑜𝑛𝑡𝑟𝑜𝑙 𝐶𝐹𝑈𝑠
 ×100   (3) 
 
For SEM analysis, the fibres were incubated for 120 min with 15 µl of a 1 x107 
CFUs/mL bacterial cell suspension at 37 ºC. Sterile polystyrene (PS) disks were used as 
control. After incubation, the culture media was removed, 1 mL of 2.5 % v/v 
glutaraldehyde in PBS was added to each sample and maintained at 37 ºC for 1 h. 
Immediately after, the fibre samples were rinsed with 1 mL of distilled water and 
dehydrated using sequential ethanol-water dilutions with increasing percentages of 
ethanol (55.0 %, 70.0 %, 80.0 %, 90.0 %, 95.0 % and 100.0 % v/v of ethanol). Samples 
were submerged in 0.5 mL of each solution for 30 min at RT. Finally, the samples were 
dried at 37 ºC for a period of 30 min prior to coating with Au/Pd using a sputter coater 
and analysed by SEM (NanoSEM - FEI Nova 200). 
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Cell culture and cytotoxicity evaluation:  
NCTC 2544 (human keratinocytes) and BJ-5ta (telomerase-immortalized normal human 
skin fibroblasts) cell lines were obtained from the American Type Culture Collection 
(ATCC, through LGC standards, Teddington, Middlesex, UK). Cells were cultured at 
37 ºC, 5 % CO2, in humidified environment and according to ATCC recommendations: 
BJ-5ta medium – 4 parts of Dulbecco’s modified Eagle’s medium containing 4 mM L-
glutamine, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate, and 1 part of Medium 199, 
supplemented with 10 % (v/v) of foetal bovine serum (FBS), 1 % (v/v) 
penicillin/streptomycin solution and 10 µg/mL hygromycin B; NCTC medium – 93 % 
(v/v) Dulbecco’s modified Eagle’s medium containing 4 mM L-glutamine, 4.5 g/L 
glucose, 1.5 g/L sodium bicarbonate, supplemented with 7 % (v/v) of FBS. 
The materials´ cytotoxicity was assessed in BJ-5ta and NCTC 2544 cell lines. UV 
sterilized fibre samples of approximately 100 mm2 were incubated with 750 μL of cell 
culture medium without FBS for 24 h at 37 ºC, 5 % CO2 in a humidified environment. 
In parallel, 100 μL of a cell suspension of 6.6 x 104 cells/mL were seeded and cultured 
in surface treated 96-well plates (Nunclon polystyrene 96-well MicroWell, Thermo 
Scientific) for 24 h under the conditions described above. Following incubation, the cell 
culture medium was removed and replaced with the medium conditioned by the 24 h 
contact with the fibre samples. Cell viability was then evaluated after 48 and 72 h, using 
the MTS assay (CellTiter 96® Aqueous One Solution Cell Proliferation, Promega) 
according to the manufacturer’s instructions. Cells cultured in standard culture medium 
and in 30 % DMSO (Sigma-Aldrich) were used as positive and negative controls for 
cell viability, respectively. Results were expressed as percentage of viability in relation 
to the positive control (set as 100 % viability).  
 
Statistics and data analysis:  
One-way analysis of variance (ANOVA) with Bonferroni’s post-test was carried out 
using GraphPad Prism 5 Software to compare the means of the different data sets within 
each experiment. A value of P < 0.05 was considered to be statistically significant. All 
experiments were performed in triplicate.  
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Results  
Morphology and structural characterization:  
Figure 1 shows the surface morphology of CM4-A200 electrospun fibres. The fibres 
were randomly and isotropically distributed and characterized by smooth, cylindrical 
and non-defective fibres with an average diameter of 149 ± 71 nm. In order to evaluate 
if the processing technique induces structural modifications, the electrospun fibres were 
analysed by ATR-FTIR and compared with the pure lyophilized sample (figure 2). The 
infrared spectra of the fibre mats reveals the characteristic absorption bands of amide 
groups centred at 1628 cm-1 for amide I (mainly C=O stretching vibration), 1523 cm-1 
for amide II (out-of-phase combination of N-H bending and C-N stretching vibrations) 
and 1231 cm-1 for amide III (in-phase combination of N-H bending and C-N stretching 
vibrations) [33, 34]. The broad absorption band observed in the 3500 – 3100 cm-1 band 
region is attributed to contributions from amide A (N-H stretching vibration) and free 
water present in the material due to the storage conditions [33]. The same pattern was 
found for the lyophilized sample, suggesting that electrospinning did not induce 
significant structural modifications. Furthermore, the absence of the characteristic 
infrared peaks of formic acid at 1750 and 2942 cm-1 (Data from the National Institute of 
Standards and Technology) reveals the total evaporation of the solvent during sample 
processing and storage. 
 
 
Figure 1 - SEM micrographs of CM4-A200 fibres (a) and corresponding histogram 
with diameter distribution (b). A normal distribution curve was applied in the 
histogram. 
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 Figure 2: Infrared spectra of electrospun and lyophilized samples showing the 
characteristic amide absorption bands.  
 
Thermal stability and degradation 
Thermal characterization, including determination of the activation temperature, was 
assessed in the fibre mats and further compared with free standing films of CM4-A200 
produced by solvent casting. The DSC thermograms of the electrospun fibres and free 
standing films are characterized by a single broad endothermic peak centred at ~85 ºC, 
starting at the initial temperature and extending to ~150 ºC (figure 3a). For both fibres 
and films, the TGA thermogram is characterized by two major weight loss steps (figure 
3b): i) the first, at temperatures below 150 ºC, is associated to the loss of moisture [35] 
due to the handling and storage of the sample at room conditions and proved to be 
independent of the processing technique, corresponding to a weight loss of ~8 % and; ii) 
the second degradation process starts at ~300 ºC and goes up to 450 ºC and is related to 
protein degradation, namely progressive deamination, decarboxylation and 
depolymerisation arising from the break of polypeptide bonds [35, 36]. 
Regarding the initial step of weight loss, a broader band is observed in the TGA from 
films, when compared to the fibres. This result can be explained by the thicker matrix of 
the films that leads to a slower loss of water. Figure 3c depicts the derivative thermo-
gravimetric curve (DTG) profiles of CM4-A200 fibres and films. The peaks observed in 
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both graphs corroborate the two steps of degradation described above and give 
indications of the mean temperature for each thermal step.  
Protein thermal stability was characterized by the kinetic parameters of the thermal 
degradation. The Kissinger mathematical model [37, 38] was used to determine the 
activation energy from plots of the logarithm of the heating rate vs the inverse of 
temperature maximum reaction rate, in constant heating rate (𝛽) experiments: 
 
ln (
𝛽
𝑇𝑝2
) =
ln (𝐴𝐸𝑎𝑐𝑡)
𝑅
+ ln[𝑛(1 − 𝛼𝑝)
1−𝑛] −
𝐸𝑎𝑐𝑡
𝑅𝑇𝑝
 
(4) 
 
where 𝐴 is the Arrhenius pre-exponential factor (min-1), 𝑅 is the ideal gas constant (8.31 
J.mol-1.K-1), and 𝐸𝑎𝑐𝑡 is the activation energy of the thermal degradation process, where 
𝑇𝑝 and 𝛼𝑝  are the peak temperature and the conversion at the maximum weight loss rate 
[39].  
Figure 3d, represents the plots of ln(β/Tp2) versus 1/Tp for fibres and films with a linear 
regression line fitted to the data. The slope of the line equals −𝐸𝑎𝑐𝑡/𝑅, and allows the 
determination of the activation energy for the different materials. Accordingly, the 
activation energy obtained for the fibre mats was higher than that calculated for the 
films, with values of 184 and 166 kJ.mol-1, respectively.  
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 Figure 3:  Thermograms obtained by DSC (a) and TGA (b) for the CM4-A200 
materials produced by electrospinning and solvent casting. The derivative 
thermogravimetric curve (c) allows to distinguish the point at which the weight loss is 
more evident. Coloured lines represent the different heating rates utilized: black – 10 
ºC.min-1; red – 20 ºC.min-1; green – 30 ºC.min-1; blue – 40 ºC.min-1. The activation 
energy for each material was determined by the slope of the Kissinger plot (d) 
multiplied by the gas constant.  
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Hydrolytic degradation and swelling degree: 
The stability and the water uptake capability (degree of swelling) of the electrospun 
membranes was evaluated by immersing the fibre mats in PBS for different time 
intervals at 37 ºC while measuring changes in weight (figure 4). After the time course of 
30 days, the electrospun fibre mats revealed low degradation with a corresponding mass 
loss of 13 ± 10 % (figure 4a). The swelling of the fibres was very fast, reaching values 
of 611 ± 117 % after only 5 min of immersion in PBS (figure 4b). After the initial rapid 
swelling, the fibres maintained its behaviour for the remaining time of the assay, with a 
final degree of swelling of 679 ± 50 %. 
 
 
Figure 4. In vitro hydrolytic degradation profile (a) and degree of swelling (b) for 
CM4-A200 fibres immersed in PBS for 30 days at 37 ºC. The inset in (b) represents the 
degree of swelling obtained during the first 60 min of immersion.  
 
Antimicrobial activity: 
The electrospun mats were tested for their antimicrobial activity against P. aeruginosa, 
a Gram-negative bacteria, and S. aureus, a Gram-positive bacteria by a direct contact 
assay. As observed in figure 5a, the electrospun mats display antimicrobial activity 
against both P. aeruginosa and S. aureus after 120 min of incubation, causing 95.9 ± 1.6 
% and 77.0 ± 2.6 % of kill, respectively. Regarding P. aeruginosa, 30 min of incubation 
with the fibres was sufficient to achieve a % of kill of 99.0 ± 0.1 %, highlighting the 
strong antimicrobial effect of the material. The antimicrobial activity of the fibres was 
time-dependent for S. aureus, as the killing efficiency rose from 0.4 ± 1.7 %, at 30 min 
of incubation, to 77 ± 2.6 %, after 120 min of incubation.  
SEM micrographs of P. aeruginosa and S. aureus cells after 120 min of contact with the 
fibre mats clearly show altered morphology, presenting a collapsed form and an 
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apparent reduction of size (figure 5b). The loss of the fibre-like shape in the electrospun 
mats is likely a consequence of the cell fixation protocol that involves a sequence of 
several dehydration/hydration steps that could result in fibre merging.  
 
 
Figure 5 – Antimicrobial activity of CM4-A200 fibres by direct contact. a) in vitro 
assay against P. aeruginosa and S. aureus for 30 and 120 min at 37 °C; sterile 
aluminium foil squares were used as reference for 100 % survival; bars represent means 
± SD (ns, non significant, ****p ≤ 0.0001); b) SEM micrographs of P. aeruginosa (1 
and 2) and S. aureus (3 and 4) cells in contact with PS (1 and 3) and fibre mats of CM4-
A200 (2 and 4) for 120 min at 37 °C. 
 
Cytotoxicity:  
Cell viability in response to the fibre mats was assessed by indirect contact with BJ-5ta 
(fibroblasts) and NCTC 2544 (keratinocytes) cell lines (figure 6). Cytotoxicity 
evaluation on keratinocytes showed values of 88.4 ± 2.2 % of cell viability after 24 h of 
incubation, while no significant cytotoxicity was found for fibroblasts, with values of 
99.0 ± 1.4 % of cell viability. However, no significant cytotoxicity was detected after 72 
h of contact, with the keratinocytes reaching 90.9 ± 4.9 % of cell viability and the 
fibroblasts even suggesting a slight proliferative effect with 105.3 ± 3.1 % (figure 6).  
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 Figure 6 – Cytotoxicity evaluation of CM4-A200 fibre mats. Indirect contact viability 
assay was performed on normal human skin fibroblasts (BJ-5ta cell line) and human 
keratinocytes (NCTC 2544 cell line) using the MTS assay and represented as % cell 
viability related to the untreated control; bars represent means ± SD (ns, nonsignificant, 
***p ≤ 0.001). 
 
 
 
Discussion 
In this study, we describe the fabrication of antimicrobial, defective-free CM4-A200 
electrospun fibres from a 20 % (w/v) protein polymer solution prepared in formic acid. 
Previously, we have demonstrated that CM4-A200 films produced by solvent casting 
display their best antimicrobial activity when obtained from formic acid solutions [4]. In 
addition, formic acid demonstrated to be a suitable solvent, yielding a clear solution 
without any evidence of gelation, not altering the secondary structure of the protein 
polymer [4]. Therefore, the choice of the solvent was based on its ability to dissolve the 
recombinant protein while preserving the antimicrobial activity after processing.  
The produced fibres were cylindrical in shape with an average fibre diameter of 149 ± 
71 nm (figure 1), which is the lowest reported to date for an ELR. Previously, Benitez et 
al. [11] demonstrated that electrospun ribbons from an ELR functionalized with a RGD 
domain could be produced from solutions with concentrations of 25 wt% and 35 wt% in 
deionized water. These ribbon-like fibres presented an average fibre diameter of 1.2 ± 
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0.3 µm and 1.8 ± 0.4 µm, for 25 and 35 wt%, respectively. Similarly, García-Arévalo et 
al. [14] described the production of electrospun ribbon-like fibres with diameters 
around 800 nm from a 25 wt% aqueous ELR solution. More recently, Putzu et al. [13] 
reported the fabrication of electrospun fibres from an ELR containing cell adhesion 
sequences prepared in 2,2,2-trifluoroethanol. The authors tested the effect of several 
experimental electrospinning parameters in fibre shape and width, demonstrating that 
fibres with an average diameter of 180 ± 57.7 nm could be obtained from a 20 % (w/v) 
protein solution. In the present work, the CM4-A200 fibres with a substantially smaller 
diameter, and their cylindrical morphology, resemble the ECM (figure 1a). These 
differences are most likely attributed to the conditions used for electrospinning (solvent 
and concentration), but also to the different amino acid composition found in CM4-
A200.  
During electrospinning, the protein solution is subjected to electrostatic and stretching 
forces that may induce conformational changes. FTIR analysis allowed to determine if 
the processing technique influences the structure of the recombinant CM4-A200. As 
demonstrated in figure 2, both the lyophilized form and fibres present similar spectra 
with the characteristic amid bands of proteins. The absence of dislocations in peak 
position or changes in peak width or shape suggests that no significant structural 
changes occur during solution preparation and subsequent processing by 
electrospinning.  
The differing dimensional architecture of films and fibres may give rise to different 
properties. For instance, while electrospinning generates nanofibrous porous mats with 
high porosity and high surface area-to-volume ratio [40], solvent casting typically leads 
to the production of thin films in a 2D dimensional arrangement with low porosity [41]. 
The thermal properties and thermal degradation kinetics are among the most important 
characterization techniques of polymeric materials to establish the temperature working 
range without loss of its properties. Differential scanning calorimetry was employed to 
study the thermal properties of dry CM4-A200 films and fibres (figure 3a), whereas the 
thermal degradation (figures 3b and 3c) and the associated kinetics (figure 3d) were 
assessed by thermal gravimetric analysis. The broad endothermic peaks encountered in 
the DSC thermograms are related to the evaporation of bound water [35, 42]. The 
absence of any other peaks in the DSC thermograms suggests that the type of 
processing, either solvent casting or electrospinning, does not significantly affect the 
thermal properties of the material and that these samples remain stable over a wide 
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range of temperatures. Analysis of the thermogravimetric curves (figure 3b) revealed 
two main stages of weight loss. The initial step of weight loss observed at temperatures 
below 150 ºC is associated to the loss of moisture and correlates with the broad 
endothermic peak observed in the DSC experiment [35]. Due to the different structural 
organization of fibres and films, the peak corresponding to the evaporation of water is 
broader in the films, extending to higher temperatures. This relates with the more 
confined matrix of the material that hinders water evaporation. The main thermal 
decomposition stage starting at ~300 ºC corresponds to the effective stage of thermal 
degradation of the tested materials and is consistent with the degradation of other 
protein-based materials [35, 43, 44]. The main differences between the two materials 
are related with the different heating rates and are the base for the thermal degradation 
kinetic analysis (figure 3d). The higher activation energy obtained for the electrospun 
mats is most likely attributed to the higher polymer chain alignment along the 
longitudinal direction of the protein fibre, promoted by the electrospinning process. This 
same behaviour can be observed when comparing the activation energies obtained for 
PLLA films and electrospun membranes [39, 45]. 
Considering skin topical applications such as wound healing promotion, the 
determination of parameters such as water uptake capability and hydrolytic degradation 
are of utmost importance due to the moisturizing nature of the wound bed. As such, the 
hydrolytic degradation profile and swelling properties of the fibre mats were studied to 
understand their behaviour under humidified conditions (figure 4). Despite the great 
interest in novel ELR-based fibrous materials for biomedical devices, there is always 
the need to stabilize the structure of the fibre mats by means of a crosslinking agent. In 
fact, uncrosslinked ELR-based electrospun mats based on the VPGXG sequence are not 
structurally stable, even at temperatures above its coacervation temperature, quickly 
disaggregating in solution [14]. Remarkably, due to the intrinsic thermal hysteresis 
behaviour of (VPAVG)200, the CM4-A200 electrospun fibre mats were stable in 
solution without the need of crosslinking agents to promote structure stabilization. 
Indeed, the electrospun mats showed a slow degradation over the time course of the 
experiment with only 13 % of weight loss after the 30 days of incubation. Nevertheless, 
this contrasts with the 1.8 % of weight loss previously found for CM4-A200 films [4] 
and can be explained by the higher surface-to-volume ratio of the electrospun fibres 
when compared with films, that provides more surface availability to contact with the 
solution molecules [46], and enhance the hydrolytic degradation process. Regarding the 
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swelling properties, the results obtained for the electrospun fibre mats are in the range 
of other electrospun rPBP [47].  
The antimicrobial activity of CM4-A200 fibre mats was tested against bacteria with 
high clinical significance, namely P. aeruginosa (Gram-negative) and S. aureus (Gram-
positive). These bacteria belonging to the ESKAPE group are leading causes of 
nosocomial infections [22] and represent a major threat in skin-related infections and 
chronic wounds [48-50]. The electrospun fibres showed a highly efficient antimicrobial 
activity against both bacteria, reaching ~100 % kill against P. aeruginosa and ~77 % kill 
for S. aureus, after 120 min of cells contact.  The difference found for the antimicrobial 
activity in S. aureus is most likely due to the ability of the bacterial cells to form 
aggregates, reducing the direct contact with the fibres [4]. In opposition to antibiotics, 
which act in specific intracellular targets, AMPs mostly interact with the negatively 
charged bacterial cell membranes through electrostatic forces, inducing physical 
changes and damaging the biological membranes [26-28, 51]. Although not being 
clearly understood, the antimicrobial action of ABP-CM4 is generally accepted to be a 
consequence of an interaction with the cell membrane, leading to the formation of 
transmembrane pores that result in cell death [52]. This action at the cell is in agreement 
with our results suggesting that the antimicrobial activity of the fibres is a time-
dependent event that implies a direct contact with the bacterial cells. In fact, we have 
previously demonstrated that the antimicrobial activity of CM4-A200 based materials is 
not Gram-specific, is mediated by direct contact and not related with diffusion of the 
AMP [4]. 
Cytotoxicity to human cells is an important parameter to be evaluated during the 
validation of biomedical materials. In this work, cytotoxicity was evaluated in vitro by 
indirect contact (exposure to leachables) using the MTS assay, which gives an 
indication of cell metabolic activity. Despite the low hydrolytic degradation observed in 
PBS, the tested leachables were prepared with culture medium supplemented with fetal 
bovine serum, which contains several proteases that can degrade the protein-based 
materials [4]. Results of the exposure of BJ-5ta (fibroblasts) and NCTC 2544 
(keratinocytes) cell lines to the leachables of the fibre mats revealed no significant 
cytotoxicity after 72 h of contact. In fact, a slight proliferative effect was even observed 
for the BJ-5ta cell line after 72 h of contact. This effect was previously observed in 
other studies and attributed to the presence of the ELR [4, 19]. In the future, the possible 
application of this material for wound healing will be considered as chemically 
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synthesized elastin-like recombinamers (ELRs), based on the sequence VPAVG, 
showed very good biocompatibility in rats after intravitreal injection in the right eye and 
subcutaneous injection in the hind paw [53]. Also, an ELR based on the sequence 
VPAVG showed no haemolytic activity in fresh blood collected from mice [54]. 
Finally, a chemically synthesized ABP-CM4 did not display haemolytic activity in fresh 
human red blood cells [55]. 
 
Conclusions 
This work describes, for the first time, the fabrication of non-crosslinked electrospun 
fibres of an ELR-based material functionalized with an antimicrobial peptide. It is 
noteworthy that the electrospun fibre mats were stable at the handling temperature, even 
in solution, which contrasts with previous works with electrospun fibres of ELRs. This 
avoids the use of crosslinking procedures that may react with fundamental amino acids 
of the antimicrobial domain thus potentially affecting its activity. We also provide, for 
the first time, a comparison of the thermal degradation profile and kinetics of materials 
obtained by two different processing techniques (electrospinning and solvent casting), 
using the same polymeric protein-based material. In this regard, the CM4-A200 fibre 
mats proved to be more thermally stable than the films, showing a higher thermal 
degradation activation energy.  
The electrospun materials displayed a high antimicrobial activity against clinically 
relevant Gram-negative and Gram-positive bacteria, and proved to be non-cytotoxic in 
in vitro cultures of human keratinocytes and normal skin fibroblasts.  
This work represents a major advance for the development and application of protein-
based materials suitable for biomedical applications, especially those requiring 
antimicrobial properties such as in the prevention of skin wound infections. For 
instance, as wound dressings for burn healing and skin reconstruction in which 
antibacterial properties are of utmost importance. Further, it also contributes to 
understand and expand the applicability of recombinant protein-based materials by 
providing valuable information on the thermal properties of the different processed 
CM4-A200 materials, an important parameter in materials science. 
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